News

Special offer for the BioM community: Free passes for the "Festival of Biologics 2024" in Basel!

The Festival of Biologics is Europe's Largest Biologics Event and addresses the topics discovery, development, manufacturing, fill & finish and market access.

BioM is very happy to offer our biotech community FREE PASSES for the event: Please get in contact with Ms. Ariane Doischer: doischer@bio-m.org.

The event is for the leaders of the world’s biologic drug developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. Here are the key facts for this year's event:

Date: 15-17 October 2024
Venue: Hall1, Messe Basel, Switzerland

What is the Festival of Biologics?

The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry, covering the start to finish of biologics from discovery, through development, to manufacturing, clinical trials and commercialisation. 13 tracks across 3 days explore these key topic areas across antibody therapies, immunotherapeutic and biosimilars, with 350+ speakers delivering presentations, participating in panel discussions and leading roundtables.

Attendees: Join 3000+ experts from academia, pharma, biotech, regulators and investment, from across Europe and around the world

Exhibition: 150 leading solution providers to meet your needs across discovery, development, manufacturing, fill finish and market access

Start-ups: Discover 80 new and innovative companies on the exhibition floor and during the dedicated “meet the start-ups” on day 1

Networking: Connect with thousands of biologics experts in 12+ hours of built-in 1-2-1 networking

The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.

Visit the event website for more information.

Join the Festival of Biologics 2024 in Basel!
 


Newsletter

Subscribe

Archive